Your browser doesn't support javascript.
loading
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Duffaud, Florence; Italiano, Antoine; Bompas, Emannuelle; Rios, Maria; Penel, Nicolas; Mir, Olivier; Piperno-Neumann, Sophie; Chevreau, Christine; Delcambre, Corinne; Bertucci, François; Boudou-Rouquette, Pascaline; Cancel, Mathilde; Perrin, Christophe; Saada-Bouzid, Esma; Monard, Laure; Schiffler, Camille; Chaigneau, Loic; Hervieu, Alice; Collard, Olivier; Bouvier, Corinne; Vidal, Vincent; Chabaud, Sylvie; Blay, Jean-Yves.
Afiliação
  • Duffaud F; Aix Marseille Univ, APHM Hopital La Timone, Medical Oncology Unit, Marseille, France. Electronic address: florence.duffaud@ap-hm.fr.
  • Italiano A; Medical Oncology Unit, Institut Bergonié, Bordeaux, France.
  • Bompas E; Medical Oncology Department, Centre René Gauducheau, Saint Herblain, France.
  • Rios M; Medical Oncology, Institut de Cancérologie de Lorraine - Alexis Vautrin, Vandoeuvre Les Nancy, France.
  • Penel N; Medical Oncology Department, Centre Oscar Lambret and Lille University Hospital, Lille, France.
  • Mir O; Medical Oncology Department, Gustave Roussy, Villejuif, France.
  • Piperno-Neumann S; Medical Oncology Department, Institut Curie, Paris, France.
  • Chevreau C; Medical Oncology Department, Institut Universitaire de Cancérologie de Toulouse, Oncopole, Toulouse, France.
  • Delcambre C; Medical Oncology Department, Centre François Baclesse, Caen, France.
  • Bertucci F; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France.
  • Boudou-Rouquette P; Medical Oncology Department, Centre Hospitalier Universitaire Cochin, APHP, Paris, France.
  • Cancel M; Medical Oncology Department, Centre Hospitalier Régional Universitaire Bretonneau, Tours, France.
  • Perrin C; Medical Oncology Unit, Centre Eugène Marquis, Rennes, France.
  • Saada-Bouzid E; Medical Oncology Department, Centre Antoine Lacassagne, Nice, France.
  • Monard L; Unicancer, Paris, France.
  • Schiffler C; Department of Statistics, Centre Léon Bérard, Lyon, France.
  • Chaigneau L; Medical Oncology Department, Centre Hospitalier Universitaire - Jean Minjoz Hospital, Besançon, France.
  • Hervieu A; Medical Oncology Department, Centre Georges Francois Leclerc, Dijon, France.
  • Collard O; Medical Oncology Department, Institut de Cancérologie Lucien Neuwirth, St Priest En Jarez, France.
  • Bouvier C; Aix Marseille Univ, APHM Hopital La Timone, Pathology Department, Marseille, France.
  • Vidal V; Aix Marseille Univ, APHM Hopital La Timone, Radiology Department, Marseille, France.
  • Chabaud S; Department of Statistics, Centre Léon Bérard, Lyon, France.
  • Blay JY; Medical Oncology Department, Centre Léon Bérard, Lyon, France.
Eur J Cancer ; 150: 108-118, 2021 06.
Article em En | MEDLINE | ID: mdl-33895682
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Ósseas / Condrossarcoma / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Ósseas / Condrossarcoma / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article